Cargando…

The effects of rivaroxaban, an oral anticoagulant, on human IVD primary cultures

INTRODUCTION: The present study aimed to investigate the potential effects of rivaroxaban, an oral anticoagulant that inhibits the effects of factor Xa, on intact intervertebral disc tissue cells and the extracellular matrix (ECM). MATERIAL AND METHODS: Rivaroxaban was applied to primary human cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caliskan, Tezcan, Akalan, Hande, Yilmaz, Ibrahim, Karaarslan, Numan, Sirin, Duygu Yasar, Ozbek, Hanefi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2021
Materias:	Basic Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266726/ https://www.ncbi.nlm.nih.gov/pubmed/35832710 http://dx.doi.org/10.5114/aoms/136323

Ejemplares similares

Effect of naproxen on proliferation and differentiation of primary cell cultures isolated from human cartilage tissue
por: Karaarslan, Numan, et al.
Publicado: (2018)

Effects of etanercept, a tumor necrosis factor receptor fusion protein, on primary cell cultures prepared from intact human intervertebral disc tissue
por: Caliskan, Tezcan, et al.
Publicado: (2019)

Evaluation of the effects of pregabalin on chondrocyte proliferation and CHAD, HIF-1α, and COL2A1 gene expression
por: Sirin, Duygu Yasar, et al.
Publicado: (2018)

Investigation of the effect of dipyrone on cells isolated from intervertebral disc tissue
por: Akgun, Feride Sinem, et al.
Publicado: (2019)

Does Nimodipine, a Selective Calcium Channel Blocker, Impair Chondrocyte Proliferation or Damage Extracellular Matrix Structures?
por: Kaplan, Necati, et al.
Publicado: (2019)

Toxicity of the acetyl-para-aminophenol group of medicines to intact intervertebral disc tissue cells
por: Karaarslan, Numan, et al.
Publicado: (2021)

The association between different molecular weights of hyaluronic acid and CHAD, HIF-1α, COL2A1 expression in chondrocyte cultures
por: Sirin, Duygu Yasar, et al.
Publicado: (2018)

Pregabalin treatment for neuropathic pain may damage intervertebral disc tissue
por: Karaarslan, Numan, et al.
Publicado: (2018)

Iopromide- and gadopentetic acid-derived preparates used in MR arthrography may be harmful to chondrocytes
por: Oznam, Kadir, et al.
Publicado: (2017)

Rapidly progressing interhemispheric subdural empyema showing a three-fold increase in size within 12 hours: Case report
por: Yüksel, Mehmet O., et al.
Publicado: (2016)

Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
por: Turpie, Alexander GG
Publicado: (2014)

The IVD Directive and Availability of Reference Systems for IVD Medical Devices: A View from Industry
por: Greenberg, Neil
Publicado: (2001)

Toward Patient Specific Models of Pediatric IVDs: A Parametric Study of IVD Mechanical Properties
por: Pickering, Edmund, et al.
Publicado: (2021)

Advances in oral anticoagulation treatment: the safety and efficacy of rivaroxaban in the prevention and treatment of thromboembolism
por: Turpie, Alexander G.G.
Publicado: (2012)

Effects of direct oral anticoagulants dabigatran and rivaroxaban on the blood coagulation function in rabbits
por: Yin, Lu, et al.
Publicado: (2022)

Stroke Prevention in Atrial Fibrillation: Understanding the New Oral Anticoagulants Dabigatran, Rivaroxaban, and Apixaban
por: Ru San, Tan, et al.
Publicado: (2012)

Rivaroxaban and other non-vitamin K antagonist oral anticoagulants in the emergency treatment of thromboembolism
por: Goldstein, Patrick, et al.
Publicado: (2013)

Direct oral anticoagulants in pediatric venous thromboembolism: Review of approved products rivaroxaban and dabigatran
por: Al-Ghafry, Maha, et al.
Publicado: (2022)

Epigenetic IVD Tests for Personalized Precision Medicine in Cancer
por: Beltrán-García, Jesús, et al.
Publicado: (2019)

Oral Rivaroxaban Versus Standard Therapy in Acute Venous Thromboembolism Treatment for Vietnamese Patients
por: Bui, My Hanh, et al.
Publicado: (2019)

Unmet Needs in Anticoagulant Therapy: Potential Role of Rivaroxaban
por: Eikelboom, John W., et al.
Publicado: (2015)

Leukocytoclastic Vasculitis Associated with a New Anticoagulant: Rivaroxaban
por: Hasbal, Nuri Barış, et al.
Publicado: (2017)

Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
por: Stolz, Leonie, et al.
Publicado: (2017)

Monitoring of Anticoagulant Activity of Dabigatran and Rivaroxaban in the Presence of Heparins
por: Jakimczuk, Aleksandra, et al.
Publicado: (2022)

A New Test for the Detection of Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in the Emergency Room Setting
por: Frydman, Galit H., et al.
Publicado: (2019)

Bleeding risks with novel oral anticoagulants especially rivaroxaban versus aspirin: a meta-analysis
por: Chen, Xiehui, et al.
Publicado: (2021)

Harmonization of Clinical Laboratory Test Results: The Role of the IVD Industry
por: Armbruster, Dave, et al.
Publicado: (2016)

Alliance of IVD manufacturer and medical laboratory for quality control of results
por: Pradella, Marco
Publicado: (2021)

Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban
por: Winkle, Roger A., et al.
Publicado: (2014)

Accidental Rivaroxaban Overdose in a Patient with Pulmonary Embolism: Some Lessons for Managing New Oral Anticoagulants
por: Sajkov, Dimitar, et al.
Publicado: (2015)

The effect of a new oral anticoagulant (Rivaroxaban) on implants pull-out strength. An experimental study in rats
por: Kapetanou, Artemis G., et al.
Publicado: (2017)

Anticoagulant effects of rivaroxaban, prednisone, alone and in combination, in healthy dogs
por: Hafner, Paige M., et al.
Publicado: (2022)

Spontaneous haemorrhagic cholecystitis secondary to the use of novel anticoagulants (rivaroxaban)
por: Kurian, Merina, et al.
Publicado: (2023)

Current status of development of methylation biomarkers for in vitro diagnostic IVD applications
por: Taryma-Leśniak, Olga, et al.
Publicado: (2020)

Rivaroxaban and other novel oral anticoagulants: pharmacokinetics in healthy subjects, specific patient populations and relevance of coagulation monitoring
por: Mueck, Wolfgang, et al.
Publicado: (2013)

The direct oral anticoagulants rivaroxaban and dabigatran do not inhibit orthotopic growth and metastasis of human breast cancer in mice
por: Buijs, Jeroen T., et al.
Publicado: (2019)

Rivaroxaban Related Bilateral Adrenal Hemorrhage: A Rare Complications of Direct Oral Anticoagulants – A Case Reports
por: Alidoost, Marjan, et al.
Publicado: (2019)

Mortality associated with the use of non‐vitamin K antagonist oral anticoagulants in cancer patients: Dabigatran versus rivaroxaban
por: Lin, Yu‐Sheng, et al.
Publicado: (2021)

Is it necessary to alter anticoagulation therapy for tooth extraction in patients taking direct oral anticoagulants?
por: Caliskan, Mehmet, et al.
Publicado: (2017)

Are We Economically Efficient Enough to Increase the Potential of in Vitro Proliferation of Osteoblasts by Means of Pharmacochemical Agents?
por: Isyar, Mehmet, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_viq10384eghmia8f1a0r12h3ud